Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2020 May 19;26(8):1394–1401. doi: 10.1016/j.bbmt.2020.04.011

Table 6.

Stem Cell Collection Data: 6 Induction Cycles

Parameter VRD Arm KRD Arm
Precollection BM cellularity, %, mean ± SD (P = .148) 35.8 ± 13.1 39.2 ± 15.1
Time from end of induction therapy to start of collection, d, median (range) (P = .479) 29 (10-100) 24 (9-195)
G-CSF and plerixafor-based stem cell mobilization, n (%) 39 (92.9) 89 (98.9)
Chemotherapy-based stem cell mobilization, n (%) 3 (7.1) 1 (1.1)
Premobilization hematologic parameters, mean ± SD
 WBCs (P =.03) 6 ± 2.7 4.9 ± 2.2
 Hemoglobin (P = .0001) 12.5 ± 1.3 11.4 ± 1.1
 Platelets (P = .498) 198.3 ± 63.9 209.8 ± 89.3
WBC count at start of collection, mean ± SD (P = .354) 48.9 ± 16.5 46 ± 18.9
Days to complete stem cell collection, mean (P = .024) 1.81 2.21
 1 day, % 40 30
 2 days, % 40 32.2
 3 days, % 16.7 27.8
 4 days, % 2.4 10
Collection failures (<2 × 106 CD34+ cells/kg), n (%) (P = .9) 1 (2.4) 6 (6.7)
Suboptimal collection(<5 × 106 CD34+ cells/kg), n (%) 2 (4.8) 16 (17.8)